A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma

被引:37
作者
Hamano, A
Tanaka, S
Takeda, Y
Umeda, M
Sakata, Y
机构
[1] Nissui Pharmaceut Co Ltd, Cent Res Lab, Yuki, Ibaraki 3070036, Japan
[2] Jichi Med Sch, Div Cell & Mol Biol, Minami Kawachi, Tochigi 3290498, Japan
关键词
monoclonal antibody (MoAb); fibrin monomer (FM); soluble fibrin (SF) complex; enzyme-linked immunosorbent assay (ELISA); disseminated intravascular coagulation (DIC);
D O I
10.1016/S0009-8981(01)00779-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Soluble fibrin (SF), composed of fibrin monomer (FM) and fibrinogen, is well known to exist in the circulating blood derived from patients with thrombotic diseases, and its quantification is useful to get some information on the state and degree of intravascular coagulation. However, there was no convenient method for the determination of SF. Methods: We prepared a novel monoclonal antibody (MoAb) (17405) to FM and SF using desAA-fibrin as the immunogen in the presence of anti-polymerant peptide (Gly-Pro-Arg-Pro, GPRP), and the characterization of the F405 was performed by Western blotting analysis and an enzyme-linked immunosorbent assay (ELISA). We also tried to detect SF in human plasma using an ELISA involving the immobilized F405 and horseradish peroxidase (POD)-labeled anti-fibrinogen polyclonal antibody. Results: The antibody reacted with the fibrin degradation products fragments X, Y and E, but not with Fibrinogen or its fragments X, Y, D and E, or the fibrin D-dimer. The epitope recognized by F405 appeared to be the alpha-chain N-terminal region exposed upon removal of the A peptide from the Aalpha-chain because F405 was found to bind to the alpha-chain N-terminal oligo-peptide of fibrin (GPRVVERHQ). Since F405 reacted not only with FM in the presence of GPRP peptide, but also with the SF complex prepared by the addition of thrombin-treated FM to human fibrinogen, we attempted to detect SF in human plasma using ELISA. The analytical range of this method was 1-300 mug/ml. The assay detection limit was < 0.5 mug/ml, and the results of intra- and inter-assay precision studies indicated that this method is accurate and yields reproducible results (< 9.4% and < 10%, respectively). When 56 samples of plasma from patients with disseminated intravascular coagulation (DIC) and 117 control samples from healthy individuals were tested, elevated levels of SF complex were detected in the DIC samples: the mean +/- S.D. of the SF concentration in the DIC and control samples were 63.4 +/- 65.3 mug/ml and 1.9 +/- 1.0 mug/ml, respectively. Conclusions: The ELISA using F405 is useful for the diagnosis of DIC. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 26 条
[1]   FIBRIN FORMATION - ROLE OF FIBRINOGEN-FIBRIN MONOMER COMPLEX [J].
BRASS, EP ;
FORMAN, WB ;
EDWARDS, RV ;
LINDAN, O .
THROMBOSIS AND HAEMOSTASIS, 1976, 36 (01) :37-48
[2]   LABORATORY METHODS FOR DETECTING DISSEMINATED INTRAVASCULAR COAGULATION (DIC) - NEW ASPECTS [J].
BREDBACKA, S ;
BLOMBACK, M ;
WIMAN, B ;
PELZER, H .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1993, 37 (02) :125-130
[3]   FIBRIN POLYMERIZATION SITES IN FIBRINOGEN AND FIBRIN FRAGMENTS [J].
BUDZYNSKI, AZ ;
OLEXA, SA ;
PANDYA, BV .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 408 (JUN) :301-314
[4]   BINDING OF A NEW MONOCLONAL-ANTIBODY AGAINST N-TERMINAL HEPTAPEPTIDE OF FIBRIN ALPHA-CHAIN TO FIBRIN POLYMERIZATION SITE-A - EFFECTS OF FIBRINOGEN AND FIBRINOGEN DERIVATIVES, AND PRETREATMENT OF SAMPLES WITH NASCN [J].
DEMPFLE, CE ;
DOLLMAN, M ;
LILL, H ;
PUZZOVIO, D ;
DESSAUER, A ;
HEENE, DL .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (01) :79-86
[5]  
GREFF H, 1979, THROMB RES, V16, P575
[6]   CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].
KOHLER, G ;
MILSTEIN, C .
NATURE, 1975, 256 (5517) :495-497
[7]   SYNTHETIC PEPTIDE DERIVATIVES THAT BIND TO FIBRINOGEN AND PREVENT POLYMERIZATION OF FIBRIN MONOMERS [J].
LAUDANO, AP ;
DOOLITTLE, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (07) :3085-3089
[8]   A NEW IMMUNOASSAY FOR SOLUBLE FIBRIN ENABLES A MORE SENSITIVE DETECTION OF THE ACTIVATION STATE OF BLOOD-COAGULATION INVIVO [J].
LILL, H ;
SPANNAGL, M ;
TRAUNER, A ;
SCHRAMM, W ;
SCHULLER, D ;
OFENLOCHHAEHNLE, B ;
DRAEGER, B ;
NASER, W ;
DESSAUER, A .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (01) :97-102
[9]   FIBRINOGEN TOKYO-II - AN ABNORMAL FIBRINOGEN WITH AN IMPAIRED POLYMERIZATION SITE ON THE ALIGNED DD DOMAIN OF FIBRIN MOLECULES [J].
MATSUDA, M ;
BABA, M ;
MORIMOTO, K ;
NAKAMIKAWA, C .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) :1034-1041
[10]   Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy [J].
McCarron, BI ;
Marder, VJ ;
Francis, CW .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) :1722-1729